Appointments and Honors

Medical Director of UW Health Eye Clinic – Rockford

Subspecialty

Retina, macula and vitreous diseases

Medical and Surgical Interests

• Age-related macular degeneration
• Diabetic retinopathy
• Medical retina disease
• Retinal vascular disease

Research Interests

• Vitreoretinal clinical trials

Research Highlights

Dr. Gottlieb contributed to the clinical data of a formative study published in the New England Journal of Medicine that found that the anti-VEGF inhibitors, aflibercept, bevacizumab, or ranibizumab improved visual acuity for those that suffer from diabetic macular edema. Interestingly, when participants had worse visual acuity at baseline, alibercept was more effective in improving vision. The study was conducted through the Diabetic Retinopathy Clinical Research Network and included more than 89 clinical sites. The outcomes have far-reaching implications for clinical treatment of macular edema and have been cited over 600 times to date.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

Education

Fellowships: Surgical Retina, Wills Eye Hospital, Philadelphia, PA; Medical Retina, Bascom Palmer Eye Institute, Miami, FL

Residency: University of Michigan Kellogg Eye Center, Ann Arbor, MI

Internship: Pacific Presbyterian Medical Center, San Francisco, CA

Medical School: Duke University School of Medicine, Durham, NC